TGFB1 and neoplasm: The use of nanoparticles (NPs) containing small interfering RNA (siRNA) to knock-down TGF-β in the tumor microenvironment has resulted in increased levels of CD8+ T cells and lower number of Treg cells, leading to tumor growth inhibition by 52% (Xu et al., 2014).